OptionsHouse

Options Trading News

December 20, 2012  Thu 7:28 AM CT

ILMN: SEE CHART GET CHAIN FIND STRATEGIES
Roche Comes Back to the Table

Illumina has been a target of M&A chatter before, and it's back in the headlines today. Swiss newspaper L'Agefi reported that Roche Holding may try to buy the company for $66 a share. ILMN, which closed at $52.17 yesterday, is up 7 percent before the bell on my tradeMONSTER platform.

Motorola Deal Lifts Arris Shares

Arris Group agreed to purchase Motorola Home from Google for $2.35 billion in cash and stock. The deal will also increase ARRS's patent portfolio and give it access to a range of Motorola Mobility's intellectual property. ARRS rose 7 percent in early trading.

Allscripts Down on New Direction

Allscripts Healthcare decided not to sell itself and will instead try to rebuild under new leadership. It fired old CEO and gave the reins to a board member who formerly ran competitor Cerner. The change of direction is sending MDRX down by 16 percent in the premarket.

Amicus Plunges on Drug-Trial Data

Amicus Therapeutics said that its migalastat HCl drug candidate for the treatment of Fabry disease failed to meet goals in a key Phase 3 trial. FOLD craters 45 percent on the news.
Share this article with your friends


Invest Like a Monster - San Diego: June 26-27

Premium Services

Education & Strategy

Introduction to Synthetics

"Synthetics" is the name given to the relationship of two separate positions, constructed differently, that have the same exact risk and reward at each and every price level. They say that there is more than one way to skin a cat...well, there is always more than one way to create an option position...

View more education articles »